Experimental Production of Cutaneous Calcinosis and Sclerosis with Dihydrotachysterol (AT-10) 1  by Selye, Hans
EXPERIMENTAL PRODUCTION OF CUTANEOUS CALCINOSIS
AND SCLEROSIS WITH DIHYDROTACHYSTEROL (AT1O)*
HANS SELYE, M.D., Pri.D., D.Sc.
It was observed some twenty-five years ago that rats treated with parathyroid
extract during the first days of life develop a cutaneous disease which, in many
respects, closely resembles scieroderma. The condition begins with a hardening
of the skin on the back, and extends bilaterally from the forehead to about the
middle of the thorax. Then, the indurated plaques become whitish and even-
tually tend to exulcerate, leaving behind a hairless atrophic skin. Histologically,
during the acute stage, there is edema and marked calcium deposition in the
derma of the affected areas, and if the process is sufficiently severe, the entire
calcified layer eventually becomes necrotic and is cast off in the form of dry
scabs. If the process is not sufficiently intense to cause widespread necrosis,
marked connective-tissue proliferation ensues and the derma becomes sclerotic
(1). Often these skin lesions are accompanied by inflammatory infiltrations, even
outside the derma, for example, in the connective tissue that surrounds the
nerves and vessels of muscles.
On the basis of these observations, several investigators have focused their
attention on possible calcium-metabolism disturbances in scieroderma, and it
has been claimed that in this disease the calcium content of the skin is some-
times considerably increased (2, 3), and that partial parathyroidectomy may
induce marked improvement (4).
In young rats acutely overdosed with parathyroid hormone, calcification in
soft tissues other than the skin does not occur as readily as in older animals.
However, the immature bones tend to respond with an extraordinarily severe
osteitis fibrosa, that greatly predisposes them to the occurrence of multiple
spontaneous fractures (5). On the other hand, more chronic overdosage with
smaller doses of parathyroid hormone produces an excessive degree of bone
formation, that tends to obliterate the marrow cavities of long bones, and pre-
sents an aspect not unlike that of the so-called "marble-bone disease" of Albers-
Schonberg. Most of these changes produced by an excess of parathyroid hor-
mone—the reactive changes in the skin, the diffuse perivascular and perineural
infiltrations and, to some extent, even the osteitis fibrosa—exhibit morphologic
characteristics of inflammation. Indeed, much before we became aware of the
role of corticoids in the regulation of the "inflammatory potential," these ob-
servations on experimental hyperparathyroidism were considered to be "an
example showing that a hormone normally produced by the body can cause
inflammation and that the parathyroid hormone might well be regarded as a
regulator of connective tissue in general ;" it was felt that this humoral factor
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might participate in the pathogenesis of "diverse forms of systemic connective-
tissue diseases" (6).
A certain relationship between parathyroid hormone and the steroids of the
Vitamin-D group was also suspected long ago, on the basis of both experimental
and clinical findings. It was shown, for example, that in young rats, heavy over-
dosage with irradiated ergosterol preparations (containing various members of
the Vitamin-D group) can produce not oniy ectopic calcium deposition in van-
ious soft tissues, but also, excessive bone absorption with the consequent de-
velopment of multiple spontaneous fractures (7—10). All these changes are
reminiscent of those seen in hyperparathyroidism. This resemblance became
particularly evident when it was found that even ectopic soft-tissue calcifica-
tion can occur in man under the influence of a hyperfunctional parathyroid
adenoma (11).
More recent progress in the chemical separation of the individual members of
the Vitamin-D group has shown that, among these, it is dihydrotachysterol
(AT-b) which most closely resembles the parathyroid hormone in its pharma-
cologic actions. This steroid can not only relieve clinical hypoparathyroid tetany
in man, it can even produce osteitis-fibrosa-like changes in the rat (12).
In view of these findings it is hardly surprising that only few dermatologists
have considered it justified to treat clinical scleroderma with AT-b. However,
interestingly, all three publications of this kind that we were able to find in the
literature uniformly reported favorable results (13—15). It is not unusual for
humoral agents to produce diametrically opposed results, depending upon dos-
age, duration of treatment and other "conditioning factors." To mention but a
few relevant examples: testosterone may cause involution or stimulation of the
spermatogenic epithelium, and folliculoids can enhance or suppress the growth
of corpora lutea, depending upon experimental conditions (16).
In view of all these considerations it was decided to determine whether a
great excess of AT-b could produce scieroderma-like lesions, under the experi-
mental conditions that made it possible for us to induce such changes with para-
thyroid hormone.
MATERIALS AND METHODS
Sixteen lactating Wistar rats, with a mean initial body-weight of 214 gm. (range: 163-228
gm), were used for our experiments. Each mother, with her litter, was placed in a separate
cage. All animals were fed exclusively on "Purina Fox Chow" and "Pablum," throughout the
experiment.
Treatment with AT-b ("Hytakerol," Winthrop Laboratories of Canada, Ltd.) was
initiated on the third day after delivery. Daily, six of the mothers received 1.25 mg. (in 1
ml. of sesame oil), and the remaining ten, 500 g. (in 0.4 ml. of sesame oil) of this steroid,
through a thin plastic catheter, by gavage.
Both the mothers and the young, of the group given 1.25 mg. of AT-b per day, became
manifestly ill within four days and, since several of the young died during the subsequent
48 hours, we decided to kill both the mothers and the surviving young after six days of
treatment. In this series histologic studies were not made.
The group receiving 500 g. of AT-b per day were in a much better condition, but even
here the mothers lost much weight and several of the young died during the first week, so
that, on the seventh day, AT-b treatment was discontinued. To help the nutrition of the
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young, the litters (originally comprising between 5 and 13 offspring) were uniformly reduced
to 5, so as to provide more milk for each of the young. All the mothers in this second series
were killed on the 20th day after initiation of AT-b treatment. Autopsy revealed extensive
calcification of the heart, aorta, peripheral vessels, kidney and gastrointestinal tract, in
each of the lactating animals of both series. Among the suckling rats of the second series,
eight were killed for histologic study at various intervals, between the 7th and the 14th
day of treatment; the others were kept under observation during four weeks, in order to
follow the clinical course of their recovery.
Histologic specimens of the skin, bones, heart, kidneys, blood-vessels and skeletal
muscles of both the mothers and their young were fixed, either in Susa solution (for subse-
quent staining with the PAS technic) or in neutral formalin (for the demonstration of
calcium deposits with the v. Kóssa technic).
RESULTS
In the litters of both experimental series, macroscopically visible skin lesions
began to appear between the fourth and the sixth day of treatment. Their inci-
dence within a litter varied from 20% to 80%. only one litter, in the group
receiving the lower dosage of AT-b, remained totally unaffected.
Usually, the disease began by the development of a few whitish, swollen
patches on the skin that covers the calvarium; these spots gradually extended
FIG. 1, A. Ten-day-old suckling rat on the seventh day after initiation of AT-b treat-
ment in its mother. Note the hairless, indurated and edematous patch of scieroderma-like
skin on the head. The front paws are severely deformed due to mu]tiple spontaneous frac-
tures. B. Section through the skin of the scalp of the above rat. The numerous dust-like
calcium granules between the epithelium and the cutaneous muscle are clearly visible
(v. Kdssa X 75). C. Seventeen-day-old suckling rat on the 14th day after the initiation of
AT-b treatment in its mother. Here the indurated skin over the scalp has become hard and
brittle. One transverse crack is clearly visible between the eyes; the frontal part of the
patch is beginning to be detached.
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FIG. 2. Low magnification of a transverse section through the scieroderma-like patch on
the head of the rat shown in Fig. 1, C. The temporal bone is on the left and the skin surface
on the right. From the top of the figure to the upper arrow, the skin is of normal appearance
and contains numerous hair follicles and sebaceous glands. Below that level, the derma is
thickened and sclerotic; it consists of newly-formed tissue. The original (dark) calcified
skin—which contains hair follicles and necrotic sebaceous glands—is in the process of
being separated from the healthy tissue by a thick layer of epithelial ingrowth that pene-
trated the area from the upper to the lower arrow. Below the lower arrow there is no epithe-
hal separation between the old calcified and the new sclerotic skin (PAS X 30). B. Higher
magnification of the healthy skin that corresponds to the region above the upper arrow in
Fig. A (PAS)< 75). C. Higher magnification of a region situated between the arrows in Fig.
A. The ingrowth of epithelium between the dark, calcified, necrotic skin on the right and
the dense, sclerotic, newly-formed derma on the left is clearly visible here (PAS X 75). D.
Higher magnification of the region below the lower arrow in Fig. A. Here, only the beginning
of an epithelial ingrowth is visible, near the upper margin of the field; elsewhere, the cal-
cified, necrotic, old skin is separated from the underlying healthy tissue only by a sclerotic
and an inflamed open wound surface (PAS X 75).
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symmetrically on both sides, towards the neck and upper thorax. In the first
experiment, which was terminated on the sixth day of treatment, the condition
did not progress beyond this point, but in the second group, the originally soft,
swollen spots eventually became confluent and formed a large, hard, yellowish
plaque on the head and neck. Still later, these plaques became dry, necrotic and
brittle, so that they tended to break up into small scabs and then to be cast off
(Fig. 1, A and C).
While these skin lesions developed, many of the suckling rats became seriously
deformed as a result of multiple spontaneous bone fractures (Fig. 1, A), similar
to those observed in our earlier work with irradiated ergosterol (7) and para-
thyroid hormone (5).
Histologic study of the skin specimens, taken at various stages in the develop-
ment of the scleroderma-like lesions, reveals that, in the indurative stage, the
derma is heavily infiltrated with calcium. On sections stained with v. Kóssa's
technic, this manifests itself by the appearance of numerous black, dust-like
granules between the epithelium and the cutaneous muscle layer (Fig. 1, B).
A few days later the entire calcified skin becomes necrotic and is demarcated
from the underlying derma by an inflammatory granuloma. Subsequently, a
thick covering of squamous epithelium grows over the granuloma and separates
it from the necrotic calcified skin layer, so that eventually the latter is cast off.
This leaves a broad, hard layer of sclerosed derma, covered by a thick epithe-
hum, but virtually deprived of hair follicles and sebaceous glands, since these
cannot regenerate after the loss of the original skin structures (Fig. 2). Only
much later does this hardened sclerotic skin eventually become thin and atrophic.
Curiously, mast-cells are extraordinarily numerous, not only in the affected skin
regions but virtually everywhere in the connective tissue of AT-lO-treated rats.
The skeletal changes, that culminate in multiple spontaneous fractures, are
characterized by a considerable deficiency in the development of both cancel-
bus and solid bone. At the same time, there is proliferation of osteoclasts and,
to a lesser degree, of fibrous tissue in the marrow cavity and underneath the
periosteum. Soft-tissue calcification was much less common in the suckling
young than in their mothers.
DISCUSSION
These experiments show that manifestations of AT-b intoxication can be
transmitted from the mother to her young through the milk. This may be due
to the excretion, by the mammary glands, either of AT-b itself, or of some
metabolic product which mediates the activity of this steroid.
It is of special interest that AT-b, a synthetic steroid of known chemical
structure, can imitate the parathyroid hormone, not only as regards the relief
of tetany and the production of osteitis fibrosa, but also with respect to the
singular effect which this hormone exerts upon the skin. It remains to be seen
whether this experimental cutaneous disease is a true replica of clinical sciero-
derma, but it resembles the latter in many respects.
Highly purified, accurately standardized and stable preparations of para-
thyroid hormone are still difficult to obtain. This has greatly handicapped the
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progress of research concerning the effect of the parathyroids upon connective
tissue in general and the skin in particular. The observations reported here will
facilitate animal experimentation concerning the pathogenesis of the peculiar
scleroderma-like skin lesions that are caused by certain regulators of calcium
metabolism. It is hoped that such studies will also further our understanding of
the mechanism conducive to the development of scleroderma in man.
SUMMARY
Experiments on lactating rats indicate that oral administration of dihydro-
tachysterol (AT-b) to the mother can result in the development of a sclero-
derma-like skin disease in her suckling young. These cutaneous lesions are often
associated with multiple spontaneous bone fractures.
It remains to be seen whether this experimental disease is fundamentally re-
lated to clinical scieroderma. However, we now have a simple, reliable means
of producing such lesions in the common laboratory rat, so that the study of
such possible relationships has become amenable to experimental analysis.
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